HomeLatest NewsFederal NewsHRSA issues proposed rule on drug pricing dispute resolution

HRSA issues proposed rule on drug pricing dispute resolution

HRSA logoThe Health Resources and Services Administration (HRSA) is proposing a dispute resolution process for 340B Drug Pricing Program hospitals and clinics that claim they have been overcharged for drugs purchased through the program.

The proposed rule, published in the Aug. 12 Federal Register, would implement the Affordable Care Act provision requiring the binding administrative dispute resolution. Under the proposed process, which also would be available to drug manufacturers, a decision-making body within the Department of Health and Human Services would review and resolve the claims.

The American Hospital Association (AHA) says it’s concerned that hospitals do not have access to the 340B drug ceiling price information that HRSA would require them to submit as part of a dispute initiation. The AHA says it is reviewing the proposed rule further and will seek feedback from its 340B member hospitals.

Comments on the proposed rule are due Oct. 11.

Stay Connected

Unified Voice Newsletter

Events This Month

May

30may11:00 am12:00 pmEmployee Accountability: How to Address Problem Behaviors and AttitudesSDAHO Webinar

30may11:00 am12:00 pmExploring an Evidence-based Toolkit and Tailoring Messages to Specific Audiences

30may11:30 am12:30 pmSerious Illness DiscussionMJHS Hospice and Palliative Care Webinar

30may12:00 pm1:00 pmOverview of Proposed IPPS Rule (FY) 2025AHA Webinar

31may9:00 am3:00 pmEmpowerED Leadership ConferenceSDAHEC Conference


By submitting this form, you are consenting to receive marketing emails from: . You can revoke your consent to receive emails at any time by using the SafeUnsubscribe® link, found at the bottom of every email. Emails are serviced by Constant Contact